Analysis of Motor Skills in Subjects Aged 55 and Over: the Role of Cognitive Abilities for Planning Movement.

NCT ID: NCT04754906

Last Updated: 2025-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

684 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-25

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Falling is an event that is more frequent and severe in older age. It can lead to a loss of autonomy and a decrease in quality of life. It is therefore important to understand this phenomenon in order to better prevent it. Among the multiple risk factors associated with falling, recent research has shown a link between the decline in cognitive abilities (i.e., the mental processes that form our knowledge, such as memory) and the risk of falling. However, the impact of this cognitive decline on motor skills is still poorly understood. The purpose of this research is to study how the changes induced by aging affect motor skills. This would make it possible to take a new look at the phenomenon of falls occurring in the elderly and, in the long term, to improve the prevention and rehabilitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mild Cognitive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

young neurotypical subjects

people from 18 to 40 years old

Sequence 1

Intervention Type OTHER

perform arm movements towards a target

Sequence 2

Intervention Type OTHER

judge the verticality of an object

Sequence 3

Intervention Type OTHER

In standing position, point as quickly as possible with the right arm at the diode that will light up in front of the participant.

elderly neurotypical subjects

people over 55 years of age

Sequence 1

Intervention Type OTHER

perform arm movements towards a target

Sequence 2

Intervention Type OTHER

judge the verticality of an object

Sequence 3

Intervention Type OTHER

In standing position, point as quickly as possible with the right arm at the diode that will light up in front of the participant.

Elderly subjects with mild cognitive impairment

people over 55 years of age, with a diagnosis of mild cognitive impairment

Sequence 1

Intervention Type OTHER

perform arm movements towards a target

Sequence 2

Intervention Type OTHER

judge the verticality of an object

Sequence 3

Intervention Type OTHER

In standing position, point as quickly as possible with the right arm at the diode that will light up in front of the participant.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sequence 1

perform arm movements towards a target

Intervention Type OTHER

Sequence 2

judge the verticality of an object

Intervention Type OTHER

Sequence 3

In standing position, point as quickly as possible with the right arm at the diode that will light up in front of the participant.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Neurotypical subjects group:

* Person aged 18 to 40 years
* Person who has given oral consent
* Affiliated to national health insurance
* Right-handed person
2. Group of elderly neurotypical subjects:

* Person over 55 years of age
* Person who has given oral consent
* Affiliated to national health insurance
* No cognitive problems (MMSE score \>26)
* Right-handed person
3. Elderly mild cognitive disorder subject group:

* Person over 55 years of age
* Person who has given oral consent
* Diagnosis of Mild Cognitive Disorder made by a neurologist at the Centre Mémoire Ressources et Recherche (CMRR) of the University Hospital of Dijon, following the recommendations of the National Institute for Aging and Alzheimer's Association (Albert et al., 2011) This diagnosis is based on psychometric tests, brain imaging and the evolution of cognitive disorders, including an MMSE test.
* Right-handed person

Exclusion Criteria

* Neurological or psychiatric history with the exception of the TCL group.
* Follow-up of drug treatment in the last three months that may affect cognitive and/or motor skills.
* Received a shoulder prosthesis on the dominant side.
* Received a hip and/or knee replacement less than a year ago.
* Disabling joint disease of the hip or knee shoulder
* Protected adults (curatorship, guardianship)
* Person deprived of their liberty b judicial or administrative decision
* Pregnant, parturient or breastfeeding woman
* Major unable to consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Dijon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Dijon Bourgogne

Dijon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Patrick MANCKOUNDIA

Role: CONTACT

0380293970 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Patrick MANCKOUNDIA

Role: primary

0380293970

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MANCKOUNDIA 2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.